Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Hsiang Lo

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Hepatocellular Carcinoma|August 23, 2021
Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) BeadsWei-Chou Chang, Hsian-He Hsu, Sung-Hua Chiu, et al.
JCO Precision Oncology|December 5, 2024
Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell CarcinomaPo-Chien Shen, Wei-Kai Chuang, Yang-Hong Dai, et al.
European Journal of Pharmacology|November 27, 2022
Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cellsJen-Fu Yang, Tzu-Min Chen, Hsin-Han Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapyWen-Yen Huang, Chia-Hung Kao, Wen-Sheng Huang, et al.
Journal of Radiation Research|October 10, 2017
Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapyHsing-Lung Chao, Shao-Cheng Liu, Chih-Cheng Tsao, et al.
Liver Cancer|July 11, 2020
Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body RadiotherapyWen-Yen Huang, Chiao-Ling Tsai, Jenny Y Que, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2020
Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation TherapyCheng-Hsiang Lo, Hsin-Lun Lee, Chih-Weim Hsiang, et al.
Eclinicalmedicine|August 21, 2025
Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisYang-Hong Dai, Po-Huang Chen, Yi-Jhih Huang, et al.
Journal of Neurosurgery. Spine|August 10, 2024
Stereotactic body radiotherapy for painful spinal metastases: a decade of experience at a single institutionKuan-Nien Chou, David J Park, Yusuke S Hori, et al.
Journal of Neurosurgery. Spine|June 27, 2025
Vertebral fracture following primary stereotactic body radiation therapy for spinal bone metastases: a decade of experienceKuan-Nien Chou, David J Park, Vivek Sanker, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Hepatocellular Carcinoma|August 23, 2021
Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) BeadsWei-Chou Chang, Hsian-He Hsu, Sung-Hua Chiu, et al.
JCO Precision Oncology|December 5, 2024
Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell CarcinomaPo-Chien Shen, Wei-Kai Chuang, Yang-Hong Dai, et al.
European Journal of Pharmacology|November 27, 2022
Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cellsJen-Fu Yang, Tzu-Min Chen, Hsin-Han Chang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapyWen-Yen Huang, Chia-Hung Kao, Wen-Sheng Huang, et al.
Journal of Radiation Research|October 10, 2017
Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapyHsing-Lung Chao, Shao-Cheng Liu, Chih-Cheng Tsao, et al.
Liver Cancer|July 11, 2020
Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body RadiotherapyWen-Yen Huang, Chiao-Ling Tsai, Jenny Y Que, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2020
Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation TherapyCheng-Hsiang Lo, Hsin-Lun Lee, Chih-Weim Hsiang, et al.
Eclinicalmedicine|August 21, 2025
Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisYang-Hong Dai, Po-Huang Chen, Yi-Jhih Huang, et al.
Journal of Neurosurgery. Spine|August 10, 2024
Stereotactic body radiotherapy for painful spinal metastases: a decade of experience at a single institutionKuan-Nien Chou, David J Park, Yusuke S Hori, et al.
Journal of Neurosurgery. Spine|June 27, 2025
Vertebral fracture following primary stereotactic body radiation therapy for spinal bone metastases: a decade of experienceKuan-Nien Chou, David J Park, Vivek Sanker, et al.
Pageof 4